Stage 1 testing and pharmacodynamic evaluation of the HSP90 inhibitor alvespimycin (17-DMAG, KOS-1022) by the pediatric preclinical testing program
Malcolm A. Smith, Christopher L. Morton, Doris A. Phelps, E. Anders Kolb, Richard Lock, Hernan Carol, C. Patrick Reynolds, John M. Maris, Stephen T. Keir, Jianrong Wu, Peter J. Houghton
Research output: Contribution to journal › Article › peer-review
27Scopus
citations
Fingerprint
Dive into the research topics of 'Stage 1 testing and pharmacodynamic evaluation of the HSP90 inhibitor alvespimycin (17-DMAG, KOS-1022) by the pediatric preclinical testing program'. Together they form a unique fingerprint.